Health Affairs, 27, no. 4 (2008): 1029-1041 doi: 10.1377/hlthaff.27.4.1029 © 2008 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Google Scholar Articles by Frew, S. E. Articles by Singer, P. A. PubMed PubMed Citation Articles by Frew, S. E. Articles by Singer, P. A. Related Collections Health Reform International Issues Pharmaceuticals Research And Technology

Biotech & Drugs

The Indian And Chinese Health Biotechnology Industries: Potential Champions Of Global Health?

India and China have made major progress toward establishing research- and innovation-based health biotechnology sectors. Local health needs, including diseases that predominantly affect the poor, have driven much of this success. We argue that emerging domestic firms can play an important role as reliable and high-quality suppliers of existing products and as innovators for global health needs. Indeed, these firms’ participation may make existing global health approaches more sustainable. However, global health stakeholders, including international donors and the Indian and Chinese governments, will need to fashion incentives for these companies to retain a strategic focus on the global poor.

                      What's this?